Esketamine-A quick-acting novel antidepressant without the disadvantages of ketamine
© 2022 Walter de Gruyter GmbH, Berlin/Boston..
Esketamine, which is an S-enantiomer of ketamine, is better than conventional antidepressants and even better than R-ketamine. This article discusses the mechanism of action of Esketamine, how different it is from other antidepressants, its side effect profile, indications for use, various routes of administration and the review of existing literature on Esketamine.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Hormone molecular biology and clinical investigation - 43(2022), 4 vom: 01. Dez., Seite 505-511 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shoib, Sheikh [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
50LFG02TXD |
|---|
| Anmerkungen: |
Date Completed 23.12.2022 Date Revised 23.12.2022 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.1515/hmbci-2021-0099 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343716240 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343716240 | ||
| 003 | DE-627 | ||
| 005 | 20231226021110.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1515/hmbci-2021-0099 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1145.xml |
| 035 | |a (DE-627)NLM343716240 | ||
| 035 | |a (NLM)35851448 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shoib, Sheikh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Esketamine-A quick-acting novel antidepressant without the disadvantages of ketamine |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.12.2022 | ||
| 500 | |a Date Revised 23.12.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 Walter de Gruyter GmbH, Berlin/Boston. | ||
| 520 | |a Esketamine, which is an S-enantiomer of ketamine, is better than conventional antidepressants and even better than R-ketamine. This article discusses the mechanism of action of Esketamine, how different it is from other antidepressants, its side effect profile, indications for use, various routes of administration and the review of existing literature on Esketamine | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a antidepressant | |
| 650 | 4 | |a esketamine | |
| 650 | 4 | |a ketamine | |
| 650 | 4 | |a major depressive disorder | |
| 650 | 7 | |a Esketamine |2 NLM | |
| 650 | 7 | |a 50LFG02TXD |2 NLM | |
| 650 | 7 | |a Ketamine |2 NLM | |
| 650 | 7 | |a 690G0D6V8H |2 NLM | |
| 650 | 7 | |a Antidepressive Agents |2 NLM | |
| 700 | 1 | |a Kotra, Madhulika |e verfasserin |4 aut | |
| 700 | 1 | |a Javed, Sana |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, Vinh-Son |e verfasserin |4 aut | |
| 700 | 1 | |a Malathesh, Barikar C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Hormone molecular biology and clinical investigation |d 2010 |g 43(2022), 4 vom: 01. Dez., Seite 505-511 |w (DE-627)NLM205276490 |x 1868-1891 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2022 |g number:4 |g day:01 |g month:12 |g pages:505-511 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1515/hmbci-2021-0099 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2022 |e 4 |b 01 |c 12 |h 505-511 | ||